FIT Biotech plc
Edit Page
Report
Scan day: 09 February 2014 UTC
24
Virus safety - good
Description: Biotech company works with monoclonal antibodies, microarrays, HIV treatment, and allergies. Lists products and services that are offered. Preclinical development in Tartu, Estonia, with base still in Tampere, Finland.
FIT Biotech - Biotechnology Innovations - Uusi rokoteteknologia tarpeen tuberkuloosin selättämiseksi - Cut'hivac - Cutaneous and Mucosal HIV Vaccination FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary
Size: 286 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | FIT Biotech - Biotechnology Innovations - Uusi rokoteteknologia tarpeen tuberkuloosin selättämiseksi - Cut'hivac - Cutaneous and Mucosal HIV Vaccination |
| Keywords: | FIT Biotech innovative medical biotechnology company engaged development commercialisation proprietary Gene Transport Unit (GTU®) technology GTU® product applications DNA vaccination immuno gene therapies Tampereen hiv-rokote vähentää viruksia veressä FIT Biotech's most important R&D activity operations devevelopment of an HIV vaccine |
| Description: | FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies. |
| IP-address: | 217.78.212.183 |
WHOIS Info
| NS | Name Server: NS1.TAAJAMA.FI Name Server: NS4.TAAJAMA.FI |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 15-jan-2001 Expiration Date: 15-jan-2016 |